📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split
65%
• 50-day avg $0.17 below $1 exchange minimum
• 12 months cash with weak price
📉 Score Deterioration
40%
• Score rose 15 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (12mo)
💹 Market Data
Market Cap$1.40M
Shares Outstanding7.42M
Float5.98M
Cash$3.44M
Debt$538.0K
Short InterestN/A
🏛 Institutional Holdings
6 institutional holders · 35.0K shares
#1
Xtx Topco Ltd
21.4K shares
#2
UBS Group AG
7.5K shares
#3
National Bank of Canada/FI/
6.0K shares
+ 3 more holders Sign up free to view →
📉 Short Interest
Short Interest391.3K
Days to Cover1.0
% of Float6.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VRAX
📊 VRAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VRAX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.